BioPharma From curing cancer to saving troubled LA Times, biotech billionaire Soon-Shiong has grand plans By Emily Willingham
Top Story Morning Read: Soon-Shiong shares good news on Adenovirus vaccine, Olympus settles kickback charges for $306M By Neil Versel
Pharma, Startups Patrick Soon-Shiong startup NantPharma building out another Amgen cancer asset By Meghana Keshavan
Health IT, BioPharma Allscripts invests $200M in Soon-Shiong’s NantHealth in software integration deal (updated) By Neil Versel
Pharma Soon-Shiong back to his roots: NantWorks acquires next-gen Abraxane in potential $1.3B deal By Meghana Keshavan
Daily Another $100M on the books for Patrick Soon-Shiong precision medicine startup NantBioscience By Meghana Keshavan
